EntryPoint Capital’s Axsome Therapeutics AXSM Stock Holding History

EntryPoint Capital’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$218K	Sell
2025 Q1	$253K	Buy
2024 Q4	–	Sell
2024 Q3	$463K	Buy
2024 Q2	$13.8K	Sell
2024 Q1	$34.9K	Buy